Caplin Point Laboratories Limited announced the Dr. Philip Ashok Karunakaran has tendered his resignation from the position of Whole-time Director and from the Board due to health reasons, effective from the close of business working hours on April 10, 2019. The Company has appointed Mr. M Panjatcharam, who was previously the Head of R&D - Quality at Sun Pharmaceuticals Industries Limited, as a Whole-time Director of Caplin Steriles Limited (Wholly Owned Subsidiary Company} and as Head of Quality, R&D and Operations for the Company's regulated markets injectable business, including US FDA approved injectable plant and DSIR recognised R&D Units CP4 & CP 5, which is now Caplin Steriles Limited.